pilocarpine hydrochloride (Vuity ophthalmic solution)

Brand name: Vuity

Generic name: pilocarpine hydrochloride

Dosage forms: ophthalmic solution 

Drug class: miotics

Vuity eye drops is a prescription medicine used to treat the symptoms of open-angle glaucoma or ocular hypertension intraocular pressure, acute angle-closure glaucoma, postoperative elevated IOP, miosis induction, and presbyopia. Vuity may be used alone or with other medications.

Vuity may cause serious side effects including:

• hives, 
• difficulty breathing, 
• swelling of your face, lips, tongue, or throat, 
• blurred vision, 
• eye pain, 
• visual impairment, 
• eye irritation, and
• excessive tearing or watering of the eye

Get medical help right away, if you have any of the symptoms listed above.

The most common side effects of Vuity include:

• headache, 
• itching, 
• feeling like something is in your eye, 
• tearing of the eye, and 
• eye pain 

Tell the doctor if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of Vuity. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

• The recommended dosage of Vuity is one drop in each eye once daily.
• If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.

Contact Lens Wear

• Contact lens should be removed prior to the instillation of Vuity. Wait 10 minutes after dosing before reinserting contact lenses.

Avoiding Contamination of The Product

• Do not touch dropper tip to any surface, as this may contaminate the contents.

Concomitant Topical Ocular Therapy

• If more than one topical ophthalmic medication is being used, the medicines must be administered at least 5 minutes apart.

Retinal Detachment

• Rare cases of retinal detachment have been reported with other miotics when used in susceptible individuals and those with pre-existing retinal disease. Patients should be advised to seek immediate medical care with sudden onset of vision loss.

Iritis

• Vuity is not recommended to be used when iritis is present because adhesions (synechiae) may form between the iris and the lens.

Pregnancy

• There are no adequate and well-controlled studies of Vuity administration in pregnant women to inform a drug-associated risk. Oral administration of pilocarpine to pregnant rats throughout organogenesis and lactation did not produce adverse effects at clinically relevant doses.

Lactation

• There is no information regarding the presence of pilocarpine in human milk, the effects on the breastfed infants, or the effects on milk production to inform risk of Vuity to an infant during lactation.